A Virtual Reality Relaxation Intervention for Clinical Staff
Feasibility and Acceptability of a Virtual Reality Relaxation Intervention for Mental Health Staff
1 other identifier
interventional
38
1 country
1
Brief Summary
Clinical staff working in mental health services experience high levels of work-related stress, burnout and poor wellbeing. They may work long hours, experience stress directly related to the emotional demands of the role and clinical responsibility, experience physical and psychological burnout and may experience high rates of workplace violence. Poorer wellbeing and high burnout amongst mental health staff has been associated with poorer quality of patient care, higher absenteeism, higher turnover rates, and low morale. Virtual reality (VR) relaxation is a technique whereby experiences of pleasant/ calming environments are accessed via a head mounted display to promote relaxation. The use of VR relaxation facilities in the workplace may provide a pragmatic approach to enabling employees to de-stress, relax and optimise their mental wellbeing and may reduce turnover and improve stress related sick leave across the National Health Service (NHS) workforce. The research will involve a pre-post-test of 5-weeks of VR relaxation for clinical staff working in mental health settings, including those working in inpatient settings and community teams. The pre-post-test will act as a feasibility trial, the primary aim is thereby to determine whether VR relaxation is feasible and acceptable amongst mental health staff. This feasibility study will evaluate the feasibility and acceptability of a 5-week course of weekly 20-minute sessions of VR relaxation for clinical staff. Feasibility and acceptability measures will be collected and summarised at the end of the trial, including percentage of those recruited who consent to take part, completion and drop-out rates, adverse events, and satisfaction with sessions. The secondary objective is to investigate the impact of the VR relaxation intervention on potential outcome measures for a randomised controlled trial (RCT), including perceived psychological stress, worry, psychological burnout, sleep quality and anxiety. The results from this study will inform a later trial by providing key parameters including recruitment, retention, acceptability, and adherence to the treatment protocol. Additionally, follow-up qualitative interviews will be conducted with staff who engaged in the VR and staff who withdrew, to develop an understanding of attitudes towards the VR relaxation intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2022
CompletedFirst Posted
Study publicly available on registry
November 1, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJanuary 30, 2024
January 1, 2024
10 months
October 7, 2022
January 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Number of wards and community teams agree to hosting the project and number that do not agree to hosting the VR relaxation project
as assessed via a tally of acceptances and refusals
Through study completion, an average of 22 months
Number of people who consent to take part
as assessed via a tally of acceptances and refusals
Through study completion, an average of 22 months
Average adherence to VR relaxation sessions and assessments
as assessed via a record of number of VR sessions and number of assessments attended, and number of VR sessions and assessments not attended
Throughout length of participation in the VR trial, 5 weeks
Number of Participants With Treatment-Related Adverse Events
as assessed via a tally of all medical effects observed and all medical effects reported by participants
Through study completion, an average of 22 months
What proportion of participants adhere to the 20-min VR session
as assessed via a record of number of VR sessions completed in full (20 minutes) and number of sessions aborted before completion
Throughout length of participation in the VR trial, 5 weeks
Secondary Outcomes (5)
Change in The Perceived Stress Scale (PSS-10) score
baseline, 5-weeks
Change in The Penn State Worry Questionnaire (PSWQ) score
baseline, 5-weeks
Change in The Oldenburg Burnout Inventory (OLBI) score
baseline, 5-weeks
Change in The Pittsburgh Sleep Quality Index (PSQI) score
baseline, 5-weeks
What proportion of participants successfully complete their personal goal, this will be measured using the Goal Attainment Scaling (GAS)
baseline, 5-weeks
Other Outcomes (8)
Change in the Visual Analogue Scale (VAS) 10-point scale score assessing Stress
Before and after each VR session, throughout length of participation in the VR trial, 5 weeks
Change in the Visual Analogue Scale (VAS) 10-point scale score assessing relaxation
Before and after each VR session, throughout length of participation in the VR trial, 5 weeks
Change in the Visual Analogue Scale (VAS) 10-point scale score assessing tiredness
Before and each each VR session, throughout length of participation in the VR trial, 5 weeks
- +5 more other outcomes
Study Arms (1)
VR Relaxation
EXPERIMENTALa 5-week course of 20-min sessions of VR relaxation
Interventions
Participants will undergo a 5-week course of 20-min sessions of VR relaxation. The VR device used will be the Oculus Quest wireless head mounted display (HMD) with two handheld controllers. The HMD and software have been provided by a Germany based company called Magic Horizons. Participants will be asked to wear the HMD and will wear headphones to hear audio. Each session will involve participants experiencing two virtual environments designed to promote relaxation, at least one of which will have a small interactive component to aid engagement. Environments will focus on nature and will be paired with soothing music or guided meditation. For example, scenes might include dolphins dancing underwater, a beach with rock pools, waterfalls, a rainforest, green meadows with flowers, mountains with lakes and/or a sandy desert. Participants will be seated throughout all sessions.
Eligibility Criteria
You may qualify if:
- Clinical staff affiliated with South London and Maudsley National Health Service Trust (SLaM) and working in inpatient and outpatient mental health settings
- Aged 18 years or older
- Capacity to provide informed consent.
You may not qualify if:
- Staff with a history of epilepsy as there is a possibility that an epileptic episode may be generated by the VR equipment
- Is aged \<18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South London and Maudsley NHS Trust
London, Greater London, BR3 3BX, United Kingdom
Related Publications (5)
Morse G, Salyers MP, Rollins AL, Monroe-DeVita M, Pfahler C. Burnout in mental health services: a review of the problem and its remediation. Adm Policy Ment Health. 2012 Sep;39(5):341-52. doi: 10.1007/s10488-011-0352-1.
PMID: 21533847BACKGROUNDd'Ettorre G, Pellicani V. Workplace Violence Toward Mental Healthcare Workers Employed in Psychiatric Wards. Saf Health Work. 2017 Dec;8(4):337-342. doi: 10.1016/j.shaw.2017.01.004. Epub 2017 Feb 6.
PMID: 29276631BACKGROUNDJohnson J, Hall LH, Berzins K, Baker J, Melling K, Thompson C. Mental healthcare staff well-being and burnout: A narrative review of trends, causes, implications, and recommendations for future interventions. Int J Ment Health Nurs. 2018 Feb;27(1):20-32. doi: 10.1111/inm.12416. Epub 2017 Dec 15.
PMID: 29243348BACKGROUNDRiches S, Azevedo L, Bird L, Pisani S, Valmaggia L. Virtual reality relaxation for the general population: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2021 Oct;56(10):1707-1727. doi: 10.1007/s00127-021-02110-z. Epub 2021 Jun 13.
PMID: 34120220BACKGROUNDLeon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011 May;45(5):626-9. doi: 10.1016/j.jpsychires.2010.10.008. Epub 2010 Oct 28.
PMID: 21035130BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Riches, PhD
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2022
First Posted
November 1, 2022
Study Start
December 1, 2022
Primary Completion
September 30, 2023
Study Completion
December 30, 2023
Last Updated
January 30, 2024
Record last verified: 2024-01